
Chipotle's AI hiring tool is helping it find new workers 75% faster
Chipotle added an AI-powered platform to its hiring process that it dubbed "Ava Cado." The platform, created by AI HR firm Paradox, is essentially a conversational chatbot that interacts with job candidates, answers questions about the company and the job, collects information about them, and ultimately can schedule interviews with human hiring managers. It can also converse in English, Spanish, French, and German.
Chipotle chief human resources officer Ilene Eskenazi said the company's growth plan was a factor in the decision to use the AI hiring technology. With projections for about 300 new restaurants opening each year with an average of 30 employees per location, the company estimates it will have somewhere between 9,000 and 10,000 new hires per year, on top of other positions opening up at existing Chipotles.
Making sure there is no friction in that process is key. Prior to rolling out Ava Cado, Chipotle managers were tasked with scheduling all of the interviews, both from people who applied online as well as during hiring events or when people came in seeking employment. That led to a lot of administrative work for managers.
Since introducing the AI chatbot, Eskenazi said Chipotle's number of applicants "has increased dramatically" and the company is also seeing about an 85% application completion rate. Ava Cado helps the job candidate by populating the application with the information they provide, cutting down the average time it takes to complete at application to around eight minutes.
"That has greatly increased our funnel so that we're serving up many more candidates for our managers to evaluate," Eskenazi said. "Maintaining our pipeline of candidates is always something that we're very focused on," she added.
Ava Cado is also tasked with managing the interview schedules for managers, who are able to block out certain times during the week and candidates can then be scheduled based on their availability.
Perhaps most importantly, Eskenazi said, is that while Ava Cado walks candidates through the application process, it also shares information about Chipotle and the job with them, so that "they're much more informed about what the job really is, and so then we know that the applicants are that much more interested in the job by the time they're meeting a hiring manager in person."
That's helping Chipotle hire faster, reducing time to hire by up to 75%, CEO Scott Boatwright told CNBC's Jim Cramer earlier this year. "We leaned into an AI hiring assistant from Paradox about six months ago that has put us on better footing from a staffing perspective," Boatwright said. "And we've been, in the eight years I've been in the organization, pushing past numbers we thought were all-time highs just last year."
Paradox has roughly 1,000 clients that use its conversational AI platform at some point in the hiring and recruiting process, including 7-Eleven, General Motors, Nestle, Marriott International and Lowe's.
Eskenazi said that Chipotle has been seeing candidates go from application to ready to hire within three and a half days thanks to Ava Cado, which previously could have been up to 12 days.
Still, much like how workers are concerned about AI taking their jobs, there are some concerns about how AI is increasingly being integrated in the hiring experience, whether that's through screening of resumes or even speaking directly to an AI powered recruiter. There are also potential concerns about the security of applicant data when interacting with AI recruiters — earlier this month, Paradox reported that a security vulnerability was detected by researchers, potentially exposing applicant names, email addresses and contact info. Paradox said none of the data was leaked or made public. Wired had previously reported the affected client was McDonald's.
Chipotle's Ava Cado AI does not screen resumes and does not make employment decisions, and Eskenazi said the company has a strong interview and training process that its managers will continue to lead and make the decisions for.
However, she said, the company is looking to expand Ava Cado's capabilities, whether that's sharing videos with candidates to give them a better view into what working at Chipotle is like, or giving applicants a prompt to also consider other locations where there may be openings nearby. There are ways AI can also be integrated into the company's learning and development programing.
"We've gotten a lot of anecdotal feedback from both general managers and candidates, and it's been incredibly strong," Eskenazi said. "I personally have been pleasantly surprised by how much candidates have enjoyed interacting with Ava."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Pressure is on for Amazon to deliver strong Q2 earnings results following big beats by Google, Microsoft
Amazon (AMZN) will announce its second quarter earnings after the bell on Thursday, and the pressure is on to show that its AI investments are paying off. The company's report follows Google's (GOOG, GOOGL) and Microsoft's (MSFT) own blowout announcements, highlighting growth across their respective cloud businesses on the back of increased customer spending on AI. Microsoft reported that its Azure business brought $75 billion in its fiscal 2025, helping to push its market capitalization past the $4 trillion mark in early trading Thursday. Microsoft is only the second company to reach the milestone behind Nvidia (NVDA). Google parent Alphabet offered up its own strong results, noting cloud revenue climbed 32% and backlog, or purchase commitments from customers not yet realized, rose 38%. Search also performed better than expected during the quarter, with sales increasing 12% year over year. Now it's Amazon's turn to show that its AI buildout is driving revenue gains for AWS. The company's stock price is up more than 6% year to date and more than 25% over the last 12 months. Alphabet is up 1.8% year to date and 12% over the last 12 months. Microsoft is up 27% and 28%, respectively. For the quarter, Amazon is expected to report earnings per share (EPS) of $1.32 on revenue of $162.1 billion, according to Bloomberg consensus estimates. The company saw EPS of $1.26 and revenue of $147.9 in the same quarter last year. AWS revenue is expected to top $30.7 billion, up 17% versus the $26.2 billion it brought in last year. But like Microsoft, Amazon says it's contending with supply constraints as demand for AI outstrips the company's ability to stand up data centers. During the company's Q1 earnings call, CEO Andy Jassy said Amazon's AI business is a multibillion-dollar annual run rate business and that it's growing triple-digit percentages year-over-year. BofA Global Research analyst Justin Post wrote in an investor note that supply growth should support revenue trends in the second half of the year, which could accelerate AWS revenue. Outside of AWS, Amazon is expected to post online store revenue of $59.1 billion, up 6%, while advertising revenue is anticipated to hit $14.9 billion, a 17% jump. 'The consumer was far more resilient than expected in 2Q, with CEO Andy Jassy saying in May that "we have not seen any attenuation of demand at this point,' Wedbush analyst Scott Devitt wrote in a note to investors ahead of earnings. '[Foreign exchange] should also have a favorable impact to International Retail sales, with the dollar weakening on a [year-over-year] basis versus most European currencies,' he added. Investors will also be on the lookout for any potential tariff impact in retail sales in the quarter and beyond, as President Trump continues to threaten higher levies on countries that don't agree to new trade deals including, most recently, India. Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley.
Yahoo
11 minutes ago
- Yahoo
Dupixent sales spur Sanofi growth, but profits fall short
Sanofi rode the growing sales wave for blockbuster immunology drug Dupixent (dupilumab) in Q2 but reported lower-than-expected profits after outlaying money to develop new treatments. Dupixent generated sales of €3.8bn ($4.35bn) for the company in the quarter, growing 21.1% over the same period in 2024. Sanofi expanded the sales reach of the drug with approvals in the lucrative chronic obstructive pulmonary disease (COPD) market. Dupixent's success pushed Sanofi's total net sales to €9.9bn, up 10% at constant exchange rate (CER). The French drugmaker said it expects annual sales growth in the high single-digits at constant currency rates, compared to a previous forecast of mid- to high-single-digit growth. In a conference call on 31 July, chief financial officer François-Xavier Roger said that whilst tariffs were not modelled into the guidance, little impact is expected on financials in 2025. Sanofi CEO Paul Hudson said: 'Eight years after market introduction, Dupixent grew by more than 20%, supported by the COPD launch. Based on strong sales performance in H1, we are refining our 2025 sales guidance to the upper end of our previous range. At the same time, we confirm our guidance of a strong business EPS rebound, which now includes all expenses from newly acquired businesses.' Sanofi confirmed it hopes to complete a €5bn share buyback programme in 2025, adding that around 80% has been repurchased to date. However, despite progressing its ownership control, earnings per share rose 1.9% to €1.59, lower than the €1.65 analysts estimated. Shares in Sanofi fell 1% at market open to €84.70 on the Paris exchange following the Q2 report posting, despite the strong growth for Dupixent. The profit miss was primarily due to an increase in research and development (R&D) expenses. Sanofi invested €1.9bn into the department as it seeks new drugs and vaccines to succeed Dupixent, wary of its outlook becoming too reliant on sales for the product. The R&D spending represented a 17.7% jump compared to Q2 last year. Sanofi also looked beyond in-house development in efforts to bolster its pipeline – the pharma company has had a busy July in the acquisition space. In July, the drugmaker concluded its buyout of Blueprint Medicines for $9.1bn and agreed to acquire vaccine developer Vicebio for an upfront payment of $1.5bn. In addition, Sanofi bought Dren Bio's bispecific antibody for $1.9bn in March 2025 and made a push into Alzheimer's with a $470m deal for Vigil Neuroscience in May. Despite M&A buzz, Sanofi shares have declined this year in comparison to other big pharma companies. This has been primarily due to vaccine regulation uncertainty in the US. Alongside the company's pipeline diversification strategy, Duxipent looks set to supply a healthy financial outlook for Sanofi. Analysis by GlobalData forecasts sales of €23.8bn by 2031. This is based on rising uptake for the drug and further indications it's set to gain approval in. GlobalData analysts said Dupixent addressed a biologics gap in the COPD market at the time of approval. "Dupixent sales spur Sanofi growth, but profits fall short" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
Quora's Poe releases a developer API with access to a bouquet of AI models
Quora's AI platform Poe announced on Thursday that it's releasing an API that allows developers to easily access different models or bots for their own applications. The API doesn't require a separate fee. Instead, usage is tracked via Poe's existing point-based subscription plans, where each model call costs a set number of points. For instance, low-quality image generation through GPT-4o in a 1:1 aspect ratio and 1024×1024 size would cost 328 points. Today, Poe's plans include the $4.99 per month plan (10 thousand points per day), the $19.99/mo plan (1 million points per month), the $49.99/mo plan (2.5 million points per month), the $99.99/mo plan (5 million points per month), and the $249.99/mo plan (12.5 million points per month). Developers will also be able to buy additional points at a rate of $30 for 1 million tokens. Add-on tokens don't come in a fixed package, so customers can pay any dollar amount to get tokens based on that rate. Through this API, developers can power tools like Cursor, Cline, Continue, Roo, and any others that work with OpenAI-compatible chat completion APIs. The platform currently provides access to more than 100 models across voice, text, image, and video generation. These multimodal models include Imagen 4, GPT Image 1, Flux Kontext, Seedream 3.0, Veo 3, Runway Gen 4 Turbo, Kling 2.1, ElevenLabs, and Lyria. 'Currently, we are working on allowing developers to take a private bot they have built on Poe and use that through an API. Plus, we are thinking about better key management for developers for the API product,' Gareth Jones, Poe's Product Lead for Creators and Developers, told TechCrunch over a call. While API provides a way for developers to use different models, Poe also offers tools aimed at consumers. Earlier this year, the company introduced a new way to allow users to easily create AI-powered apps. It also offers templates to build server bots, prompt bots, and image generation bots. At the moment, developers will need to pick and manage model use manually. Jones said that the company will consider adding budget management functionality in the future, based on developer feedback. Melden Sie sich an, um Ihr Portfolio aufzurufen.